About Journal | Editorial BoardInstructionSubscribe | Contacts Us中文
  Office
Online Submission
Manuscript Tracking
Peer Review
Office Work
Editor-in-chief
  Journal
Forthcoming Articles
Current Issue
Archive
Advanced Search
Email Alert
  Quick Search
  Advanced Search
 

 
 
 
  Latest Printed Issue  

2012  Vol.7 Number 1
Mar. 15, 2012

Content is this issue
 
 
 
 
 
 
 


1

CHEN Fang and HUANG Tai-kang
  The Significance of Applying HACCP System to Drug Quality Risk Management
    Objective To establish drug quality risk management system in order to avoid risk events and ensure safe and effective drug use. Methods Through literature study and case analysis, along with principles of HACCP, the significance of applying HACCP system to drug quality risk management was analyzed. Results and Conclusion Applying HACCP system to drug quality risk management can prevent quality risk, reduce enterprises’ cost of quality risk events, improve supervision efficiency of the government, and enhance competitive advantages of enterprises.
    2012 Vol. 7 (1): 1-3 [Abstract ] ( 49 ) [HTML 0KB] [PDF 341KB ]( 28 )


4

HE Han-zhou, and BI Kai-shun
  Advertising Credit Management of Pharmaceutical Enterprises
    Objective To provide references for advertising credit management of pharmaceutical enterprises. Methods Literature review was applied to analyze the current situation of advertising credit management of pharmaceutical enterprises in China, including existing problems and aspects to be improved. Results and Conclusion It is suggested that advertising credit management of pharmaceutical enterprises in China should be strengthened through establishing laws and regulations, and improving drug advertising credit system.
    2012 Vol. 7 (1): 4-8 [Abstract ] ( 40 ) [HTML 0KB] [PDF 396KB ]( 29 )


9

ZONG Xin and SUN Li-hua
  Choosing Appropriate Expressions of Cost-effectiveness Threshold in China
    Objective To clarify the expressions of cost-effectiveness threshold, and thus to provide suggestions for the choice of cost-effectiveness threshold expressions in China. Methods Through literature review, existing expressions of cost-effectiveness threshold were analyzed, and suggestions were put forth. Results and Conclusion There are three expressions of cost-effectiveness threshold: cost per quality adjusted life year (QALY ), cost per life year (LY) gained and cost per disability adjusted life year (DALY), each with distinct features and applicability. And under current situation, cost per QALY and cost per LY gained are more suitable for pharmacoeconomic evaluations in China.
    2012 Vol. 7 (1): 9-14 [Abstract ] ( 40 ) [HTML 0KB] [PDF 391KB ]( 24 )


15

LIU Jing and HUANG Tai-kang
  Cost-Benefit Analysis of Government Regulations of Drugs
    Objective To provide references for strengthening the regulatory functions of Drug Administration on drug production, drug distribution, drug policy making as well as drug testing. Methods Cost-benefit analysis in welfare economics and literature review were conducted. Results and Conclusion It is suggested that government regulatory practice can be adjusted by economic theories, which paves the way for government regulations of drugs.
    2012 Vol. 7 (1): 15-17 [Abstract ] ( 42 ) [HTML 0KB] [PDF 348KB ]( 25 )


18

MA Yu-lian and LI Ye
  Drug Centralized Bidding and Purchasing in China: Problems and Suggestions
   

Abstract: Objective To put forward some suggestions to standardize and improve drug centralized bidding and purchasing work in China. Methods Suggestions were put forward on the basis of analyzing the problems in drug centralized bidding and purchasing work, followed by identifying their causes. Results and Conclusion Some achievements can be seen in drug centralized bidding and purchasing work in China, although there still exist some problems in the process. Therefore, to further standardize and improve drug centralized bidding and purchasing work, it is necessary to take such measures as establishing a information-sharing database of drugs, perfecting evaluation criteria and improving pricing methods, etc.

    2012 Vol. 7 (1): 18-21 [Abstract ] ( 44 ) [HTML 0KB] [PDF 670KB ]( 21 )


22

LUO Lie, YANG Yue and HE Chun-hong
 

The Influence of EU Technical Barriers on the Export of Chinese Traditional
Patent Medicine

   

Abstract: Objective To discuss how to break through European Union (EU) technical barriers to trade restrictions of Chinese traditional patent medicine through the analysis of the export status and the influence of technical barriers to trade (TBT). Methods Specific suggestions were put forward on the basis of the analysis of the influence of EU technical barriers on trade of Chinese traditional patent medicine. Results and Conclusion It is advisable to use WTO rules, set up related technical regulations and standard systems, increase the government support of enterprise and to establish warning and rapid response mechanism, so as to break through the technical barriers.

    2012 Vol. 7 (1): 22-27 [Abstract ] ( 43 ) [HTML 0KB] [PDF 1062KB ]( 16 )


28

WANG Si-wei and SUN Li-hua
  Government Drug Pricing Range in China: Problems and Solutions
    Abstract: Objective To provide references for making government drug pricing range reasonable, so as to achieve a healthy development of pharmaceutical industry and to ease the financial burden of patients. Methods Based on the comparative analysis of the prices of government pricing drugs and non-government pricing drugs, existing problems involved in current government drug pricing range was explored, and suggestions were raised. Results and Conclusion Enlarging government drug pricing range will be the general direction of pharmaceutical regulations, which can effectively control drug use structure and drug costs in the true sense.
    2012 Vol. 7 (1): 28-30 [Abstract ] ( 38 ) [HTML 0KB] [PDF 621KB ]( 31 )


31

ZHANG Fang and ZHU Yue
  Government Controls of Patented Drug Pricing in Canada
   

Abstract: Objective To analyze the price control system of patented drugs in Canada, including the responsibilities of price review department, price control process and price control policies. Methods Literature review and comparative analysis were used to introduce in details government controls of patented drug pricing in Canada. Results and Conclusion The establishment of Patented Medicine Prices Review Board (PMPRB) as patented drug price control department, the evaluation process of price control and the controls of overpricing in Canada can provide references for the setting up of price control system of patented drugs in China.

    2012 Vol. 7 (1): 31-35 [Abstract ] ( 42 ) [HTML 0KB] [PDF 709KB ]( 18 )


36

GUO Dong-mei, and WANG Ying
  How China Deals with the International Transfer of Pharmaceutical Industry
    Abstract: Objective To deal with the international transfer of pharmaceutical industry effectively. Methods Transfer bodies and domains were analyzed on the basis of driving force study of the international transfer of pharmaceutical industry. Advantages that China has gained to deal with the transfer were discussed and the strategies that China should adopt were raised. Results and Conclusion Comprehensive considerations should be given from the following aspects: essential factors cultivating before the transfer, strategic positioning in the transfer and industrial upgrading after the transfer, etc.
    2012 Vol. 7 (1): 36-39 [Abstract ] ( 39 ) [HTML 0KB] [PDF 700KB ]( 17 )


40

GUO Ying, , TIAN Li-juan and HAN Xu
  Perfecting Drug Recall System in China: Suggestions and Methods
    Abstract: Objective To study drug recall system in China and to propose some suggestions and methods for improving it. Methods Literature review was adopted and drug recall system in U.S.A was analyzed to provide references for improving drug recall system in China. Results and Conclutions Based on the current status of drug recall system in China, suggestions for improving drug recall system in China’s are presented from the perspective of the government.
    2012 Vol. 7 (1): 40-44 [Abstract ] ( 42 ) [HTML 0KB] [PDF 780KB ]( 29 )


45

ZHUGE Li-ying and LIU Hao
  GMP Implementation Analysis of Dietary Supplements
   

Abstract: Objective To provide references for improving dietary supplement quality. Methods Theoretical analysis and empirical study were applied. Results and Conclusion The overall level of dietary supplement industry in China has been effectively improved through the implementation of dietary supplement GMP. However, some regulations have not been implemented as rigidly as expected and there still exist some misunderstandings about dietary supplement GMP. To solve the problems, GMP related laws and regulations should be reinforced, good safeguard system should be set up and GMP consciousness of enterprise management personnel should be raised substantially.

    2012 Vol. 7 (1): 45-47 [Abstract ] ( 38 ) [HTML 0KB] [PDF 513KB ]( 15 )


48

GAO Xiao-wei, LI Ye and TANG Jing-xia
  Cefuroxime Market Integration Based on Co-integration Test
    Abstract: Objective To study the situation of Cefuroxime market integration through empirical research. Methods Some bid prices of dugs in several representative provinces over the years were chosen to analyze the market integration degree through co-integration test methods. Results and Conclusion The Cefuroxime market is not completely integrated and there are divergences among different markets, which are related to dominant regional economy, numerous pharmaceutical enterprises, and different bidding and purchasing policies implemented by local governments, etc.
    2012 Vol. 7 (1): 48-51 [Abstract ] ( 44 ) [HTML 0KB] [PDF 718KB ]( 25 )


52

WU Zhi-ming and HUANG Tai-kang
  On the Promotion of the Healthy Development of Online Drug Advertising
    Abstract: Objective To build a healthy and safe environment so as to promote the development of online drug advertising. Methods Literature review and case analysis were applied to probe into the current situation of online drug advertising and to put forward suggestions for promoting the healthy development of online drug advertising. Rresults and Conclusion Online drug advertising environment purifying and consumers’ rights safeguarding can be achieved in the way of perfecting laws and regulations, monitoring strictly comprehensive websites and search engines, promoting propaganda and simplifying consumer reporting procedures, etc.
    2012 Vol. 7 (1): 52-55 [Abstract ] ( 45 ) [HTML 0KB] [PDF 911KB ]( 18 )


56

LI Shu-peng and CHEN Yu-wen
  Three Key Elements of Category Management in Drugstores
   

Abstract: Objective To elaborate on the importance of three key elements of category management, and to provide suggestions for category management in drugstores. Methods Analysis was made on the basis of domestic and foreign literatures and the actual situation of category management in drugstores in China. Results and Conclusion Three key elements of category management are: taking category as commodity management unit, focusing on the needs of consumers and achieving strategic cooperation between suppliers and retailers. The essence of category management can be fully understood only if the importance of these three key elements is realized.

    2012 Vol. 7 (1): 56-58 [Abstract ] ( 52 ) [HTML 0KB] [PDF 566KB ]( 15 )


59

MENG Ling-quan and WU Zhi-ang
  Supervision of On-line Pharmacies in China and America: Comparison and Enlightenment
    Abstract: Objective To provide references for strengthening the supervision of on-line pharmacies in China in order to promote safe drug use. Methods Based on analysis of the supervision of on-line pharmacies in China and the experiences borrowed from America, some measures were put forward. Results and Conclusion Pharmaceutical supervision departments in China should, according to the actual situation of China, work out the problems of illegitimate on-line pharmacies and illegitimate drug dealings, etc, and thus perfect supervision system of on-line pharmacies in China step by step.
    2012 Vol. 7 (1): 59-65 [Abstract ] ( 42 ) [HTML 0KB] [PDF 1026KB ]( 20 )


66

LV Dan and CHEN Yu-wen
  Diversified Management of Chain Drugstores in the U.S. and Japan and its Enlightenment to China
    Abstract: Objective To explore the management of chain drugstores in the U.S. and Japan and its enlightenment to the diversification of chain drugstores in China. Methods Through the analysis of diversified management of chain drugstores in the U.S. and Japan, the enlightenment to China was summarized. Rresults and Conclusion Based on the experiences from the U.S. and Japan, diversification of chain drugstores in China calls for clear positioning of enterprise management; expanding the scale of chain drugstores; using a variety of marketing; creating enterprise’s own brands and paying attention to information management, etc.
    2012 Vol. 7 (1): 66-69 [Abstract ] ( 44 ) [HTML 0KB] [PDF 728KB ]( 30 )
  News
More...
  Member Service
Username
Password
Register
  Links
  Visitors
  Total visitors:
  Now online:
 Copyright © 2007 Editorial Office of Asian Journal of Social Pharmacy
Support by Beijing Magtech Co.ltd  , E-mail: support@magtech.com.cn
辽icp备09025174